Cargando…
In vitro prediction of the efficacy of molecularly targeted cancer therapy by Raman spectral imaging
Mutational acquired resistance is a major challenge in cancer therapy. Somatic tumours harbouring some oncogenic mutations are characterised by a high mortality rate. Surprisingly, preclinical evaluation methods do not show clearly resistance of mutated cancers to some drugs. Here, we implemented Ra...
Autores principales: | Yosef, Hesham K., Mavarani, Laven, Maghnouj, Abdelouahid, Hahn, Stephan, El-Mashtoly, Samir F., Gerwert, Klaus |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604500/ https://www.ncbi.nlm.nih.gov/pubmed/26168967 http://dx.doi.org/10.1007/s00216-015-8875-z |
Ejemplares similares
-
Raman micro-spectroscopy monitors acquired resistance to targeted cancer therapy at the cellular level
por: Hammoud, Mohamad K., et al.
Publicado: (2018) -
Raman Microspectroscopic Evidence for the Metabolism of a Tyrosine Kinase Inhibitor, Neratinib, in Cancer Cells
por: Aljakouch, Karim, et al.
Publicado: (2018) -
Activation leads to a significant shift in the intracellular redox homeostasis of neutrophil-like cells
por: Xie, Kaibo, et al.
Publicado: (2019) -
Disabling VEGF-Response of Purkinje Cells by Downregulation of KDR via miRNA-204-5p
por: Gehmeyr, Julian, et al.
Publicado: (2021) -
Time-resolved spectroscopic and electrophysiological data reveal insights in the gating mechanism of anion channelrhodopsin
por: Dreier, Max-Aylmer, et al.
Publicado: (2021)